David A Fellows - Net Worth and Insider Trading
David A Fellows Net Worth
The estimated net worth of David A Fellows is at least $20 Million dollars as of 2024-11-13. David A Fellows is the CEO of Nightstar Therapeutics PLC and owns about 617,090 shares of Nightstar Therapeutics PLC (NITE) stock worth over $16 Million. David A Fellows is also the CVP, Pres., EuroAsia/Africa/ME of Allergan PLC and owns about 21,131 shares of Allergan PLC (AGN) stock worth over $4 Million. Details can be seen in David A Fellows's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that David A Fellows has not made any transactions after 2019-04-01 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of David A Fellows
David A Fellows Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, David A Fellows owns 1 companies in total, including Terns Pharmaceuticals Inc (TERN) .
Click here to see the complete history of David A Fellows’s form 4 insider trades.
Insider Ownership Summary of David A Fellows
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| TERN | Terns Pharmaceuticals Inc | 2021-09-28 | director |
David A Fellows Latest Holdings Summary
David A Fellows currently owns a total of 2 stocks. Among these stocks, David A Fellows owns 617,090 shares of Nightstar Therapeutics PLC (NITE) as of April 1, 2019, with a value of $16 Million and a weighting of 79.36%. David A Fellows also owns 21,131 shares of Allergan PLC (AGN) as of October 30, 2003, with a value of $4 Million and a weighting of 20.64%.
Latest Holdings of David A Fellows
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| NITE | Nightstar Therapeutics PLC | 2019-04-01 | 617,090 | 25.41 | 15,680,257 |
| AGN | Allergan PLC | 2003-10-30 | 21,131 | 193.02 | 4,078,706 |
Holding Weightings of David A Fellows
David A Fellows Form 4 Trading Tracker
According to the SEC Form 4 filings, David A Fellows has made a total of 0 transactions in Nightstar Therapeutics PLC (NITE) over the past 5 years. The most-recent trade in Nightstar Therapeutics PLC is the sale of 9,305 shares on April 1, 2019, which brought David A Fellows around $235,510.
According to the SEC Form 4 filings, David A Fellows has made a total of 0 transactions in Allergan PLC (AGN) over the past 5 years. The most-recent trade in Allergan PLC is the sale of 21,520 shares on October 30, 2003, which brought David A Fellows around $2 Million.
Insider Trading History of David A Fellows
- 1
David A Fellows Trading Performance
David A Fellows Ownership Network
Ownership Network List of David A Fellows
Ownership Network Relation of David A Fellows
David A Fellows Owned Company Details
What does Terns Pharmaceuticals Inc do?
Who are the key executives at Terns Pharmaceuticals Inc?
David A Fellows is the director of Terns Pharmaceuticals Inc. Other key executives at Terns Pharmaceuticals Inc include Chief Financial Officer Mark J. Vignola , director & 10 percent owner Carl L Gordon , and director & 10 percent owner Orbimed Advisors Llc .
Terns Pharmaceuticals Inc (TERN) Insider Trades Summary
Over the past 18 months, David A Fellows made no insider transaction in Terns Pharmaceuticals Inc (TERN). Other recent insider transactions involving Terns Pharmaceuticals Inc (TERN) include a net purchase of 5,531 shares made by Mark J. Vignola , a net sale of 47,000 shares made by Jill M. Quigley , and a net purchase of 15,531 shares made by Seokho Bryan Yoon .
In summary, during the past 3 months, insiders sold 27,235 shares of Terns Pharmaceuticals Inc (TERN) in total and bought 476,190 shares, with a net purchase of 448,955 shares. During the past 18 months, 589,991 shares of Terns Pharmaceuticals Inc (TERN) were sold and 509,363 shares were bought by its insiders, resulting in a net sale of 80,628 shares.
Terns Pharmaceuticals Inc (TERN)'s detailed insider trading history can be found in Insider Trading Tracker table.
Terns Pharmaceuticals Inc Insider Transactions
David A Fellows Mailing Address
Above is the net worth, insider trading, and ownership report for David A Fellows. You might contact David A Fellows via mailing address: 2525 Dupont Drive, Irvine Ca 92612.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
